H. Barraclough

发表

A Systematic Review of the Interobserver Variability for Histology in the Differentiation between Squamous and Nonsquamous Non-small Cell Lung Cancer

N. Pavlakis, A. Gill, D. Paech, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

M. Orlando, T. Puri, N. Rajan, 2014, Gynecologic oncology reports.

Cancer Incidence and Mortality Projections in New South Wales

R. Aitken, M. Clements, Deborah F. Baker, 2011 .

Relationship between depression and diabetes in pregnancy: A systematic review

H. Falhammar, G. Ross, I. Gallen, 2016, World journal of diabetes.

Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study

B. Curtis, T. Davis, W. Davis, 2018, Internal medicine journal.

Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.

A. Dueñas-González, M. Orlando, H. Barraclough, 2012, Gynecologic oncology.

Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT

M. Ahn, J. Yang, R. Cheng, 2014, Cancer research and treatment : official journal of Korean Cancer Association.

A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix.

A. Dueñas-González, M. Orlando, J. Zarbá, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial.

M. Ahn, Keunchil Park, Chun-Ming Tsai, 2014, European journal of cancer.

Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review.

T. Mok, P. Mitchell, M. van Kooten, 2012, Clinical lung cancer.

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

A. Dueñas-González, M. Orlando, J. Zarbá, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

Dae-Ho Lee, Joo‐Hang Kim, V. Ganju, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A. Dueñas-González, M. Orlando, J. Zarbá, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study

J. Finn, B. Curtis, T. Davis, 2018, Diabetes, obesity & metabolism.

Degree‐of‐spread artefact in the New South Wales Central Cancer Registry

H. McElroy, H. Barraclough, S. Morrell, 2008, Australian and New Zealand journal of public health.

Histology as a treatment effect modifier in advanced non‐small cell lung cancer: A systematic review of the evidence

Lachlan Standfield, L. Standfield, N. Pavlakis, 2011, Respirology.

The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase II.

B. Curtis, T. Davis, W. Davis, 2018, Diabetes research and clinical practice.

Biostatistics Primer: What a Clinician Ought to Know Subgroup Analyses

R. Govindan, H. Barraclough, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

J. R. Pereira, Joo‐Hang Kim, R. Cheng, 2013, Drugs in R&D.

Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer.

Yang Zhang, Ying Cheng, Yi-long Wu, 2014, Lung cancer.

Biostatistics primer: what a clinician ought to know--prognostic and predictive factors.

R. Govindan, H. Barraclough, Lori A. Simms, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

S. Nag, R. Chacko, R. Parshad, 2013, Breast Cancer.